These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38204927)

  • 1. Comparative reconstruction of SARS-CoV-2 transmission in three African countries using a mathematical model integrating immunity data.
    Naffeti B; BenAribi W; Kebir A; Diarra M; Schoenhals M; Vigan-Womas I; Dellagi K; BenMiled S
    IJID Reg; 2024 Mar; 10():100-107. PubMed ID: 38204927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.
    Beukenhorst AL; Koch CM; Hadjichrysanthou C; Alter G; de Wolf F; Anderson RM; Goudsmit J
    Eur J Epidemiol; 2023 Mar; 38(3):237-242. PubMed ID: 36738380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study.
    Mabuka T; Naidoo N; Ncube N; Yiga T; Ross M; Kurehwa K; Nare Nyathi M; Silaji A; Ndemera T; Lemeke T; Taiwo R; Macharia W; Sithole M
    JMIRx Med; 2023; 4():e34598. PubMed ID: 37463043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Epidemiology of SARS-CoV-2 in Tunisia (North Africa) through Several Successive Waves of COVID-19.
    Chouikha A; Fares W; Laamari A; Haddad-Boubaker S; Belaiba Z; Ghedira K; Kammoun Rebai W; Ayouni K; Khedhiri M; Ben Halima S; Krichen H; Touzi H; Ben Dhifallah I; Guerfali FZ; Atri C; Azouz S; Khamessi O; Ardhaoui M; Safer M; Ben Alaya N; Guizani I; Kefi R; Gdoura M; Triki H
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns.
    Cabore JW; Karamagi HC; Kipruto HK; Mungatu JK; Asamani JA; Droti B; Titi-Ofei R; Seydi ABW; Kidane SN; Balde T; Gueye AS; Makubalo L; Moeti MR
    Lancet Glob Health; 2022 Aug; 10(8):e1099-e1114. PubMed ID: 35659911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of age structure and vaccine prioritization on COVID-19 in West Africa.
    Taboe HB; Asare-Baah M; Yesmin A; Ngonghala CN
    Infect Dis Model; 2022 Dec; 7(4):709-727. PubMed ID: 36097593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
    Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
    medRxiv; 2021 Dec; ():. PubMed ID: 34909794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.
    Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G;
    Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study.
    Diarra M; Kebir A; Talla C; Barry A; Faye J; Louati D; Opatowski L; Diop M; ; White LJ; Loucoubar C; Miled SB
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35193893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.
    Bowman KA; Stein D; Shin S; Ferbas KG; Tobin NH; Mann C; Fischinger S; Ollmann Saphire E; Lauffenburger D; Rimoin AW; Aldrovandi G; Alter G
    mBio; 2022 Oct; 13(5):e0164722. PubMed ID: 36000735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
    Jentsch PC; Anand M; Bauch CT
    Lancet Infect Dis; 2021 Aug; 21(8):1097-1106. PubMed ID: 33811817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of COVID-19 in Amazonia: A history of government denialism and the risk of a third wave.
    Ferrante L; Duczmal LH; Capanema E; Steinmetz WAC; Almeida ACL; Leão J; Vassão RC; Fearnside PM; Tupinambás U
    Prev Med Rep; 2022 Apr; 26():101752. PubMed ID: 35242505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection fatality rate and infection attack rate of COVID-19 in South American countries.
    Musa SS; Tariq A; Yuan L; Haozhen W; He D
    Infect Dis Poverty; 2022 Apr; 11(1):40. PubMed ID: 35382879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants.
    Thompson RN; Southall E; Daon Y; Lovell-Read FA; Iwami S; Thompson CP; Obolski U
    Front Immunol; 2022; 13():1049458. PubMed ID: 36713397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging South African HIV research to define SARS-CoV-2 immunity triggered by sequential variants of concern.
    Bhiman JN; Moore PL
    Immunol Rev; 2022 Sep; 310(1):61-75. PubMed ID: 35599324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.